Sign in

CIK 0002012593

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880724208
Phone
+1 857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,490,340
in 8 filings, $4.5M under 10b5-1 plans

Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-19 Bredt David Chief Scientific Officer Option exercise 10b5-1 +6,000 $1.80 $11K 393,075
2026-02-19 Bredt David Chief Scientific Officer Option exercise · Stock Options (Right to Buy) 10b5-1 −6,000 88,080
2026-02-17 Bredt David Chief Scientific Officer Sale 10b5-1 −900 $28.02 $25K 394,675
2026-02-17 Bredt David Chief Scientific Officer Sale 10b5-1 −5,400 $28.95 $156K 389,275
2026-02-17 Bredt David Chief Scientific Officer Sale 10b5-1 −2,200 $29.59 $65K 387,075
2026-02-02 Bredt David Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +103,000 103,000
2026-01-15 Bredt David Chief Scientific Officer Sale 10b5-1 −8,300 $26.83 $223K 395,775
2026-01-15 Bredt David Chief Scientific Officer Sale 10b5-1 −200 $27.40 $5K 395,575
2025-12-31 Bredt David Chief Scientific Officer Grant or award −18,000 410,642
2025-12-31 Bredt David Chief Scientific Officer Sale −6,567 $30.05 $197K 404,075
2025-12-15 Bredt David Chief Scientific Officer Sale 10b5-1 −7,704 $29.95 $231K 393,438
2025-12-15 Bredt David Chief Scientific Officer Sale 10b5-1 −796 $30.68 $24K 392,642
2025-11-17 Bredt David Chief Scientific Officer Sale 10b5-1 −3,156 $24.84 $78K 406,486
2025-11-17 Bredt David Chief Scientific Officer Sale 10b5-1 −5,344 $25.39 $136K 401,142
2025-10-15 Bredt David Chief Scientific Officer Sale 10b5-1 −7,418 $25.73 $191K 410,724
2025-10-15 Bredt David Chief Scientific Officer Sale 10b5-1 −1,082 $26.16 $28K 409,642
2025-09-15 Bredt David Chief Scientific Officer Sale 10b5-1 −5,098 $23.88 $122K 421,544
2025-09-15 Bredt David Chief Scientific Officer Sale 10b5-1 −3,402 $24.66 $84K 418,142
2025-08-15 Bredt David Chief Scientific Officer Sale 10b5-1 −8,300 $14.98 $124K 426,842
2025-08-15 Bredt David Chief Scientific Officer Sale 10b5-1 −200 $15.79 $3K 426,642

Page 1 of 2 · 27 trades